NCT04582786View on ClinicalTrials.gov

Dose Finding Study of STR-324

PHASE2UnknownINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Pain, Acute
Interventions
DRUG

Morphine

Repeated bolus according to pain score

DRUG

Morphine HCl

Infusion of morphine HCl solution for intravenous administration

DRUG

STR-324

Infusion of solution for intravenous administration

Trial Locations (1)

H05-22

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Lead Sponsor

Alaxia SAS
All Listed Sponsors
lead

Alaxia SAS

INDUSTRY

NCT04582786 - Dose Finding Study of STR-324 | Biotech Hunter | Biotech Hunter